Acute Ischemic Stroke (AIS) Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. High Prevalence of Brain Stroke
   3. Market Restraints
      1. Challenges in Post-Stroke Rehabilitation
   4. Market Opportunities
      1. Increasing Awareness Regarding the Stroke
   5. Market Trends
      1. Advancements in Thrombectomy Devices
5. MARKET SEGMENTATION
   1. By Type
      1. Computed Tomography (CT)
      2. Magnetic Resonance Imaging (MRI)
      3. Carotid Ultrasound
      4. Cerebral Angiography
      5. Electrocardiography
      6. Echocardiography
      7. Others
   2. By Surgery Type
      1. Carotid Endarterectomy
      2. Angioplasty
      3. Endovascular Mechanical Thrombectomy
   3. By Treatment
      1. Tissue Plasminogen Activator
      2. Anticoagulant
      3. Antiplatelet
      4. Antihypertensive
   4. By Age Group
      1. Adult
      2. Geriatric
      3. Child
   5. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Abbott (U.S.)
      2. AliveCor, Inc. (U.S.)
      3. Bayer AG (Germany)
      4. Boston Scientific Corporation (U.S.)
      5. B. Braun Melsungen AG (Germany)
      6. CANON MEDICAL SYSTEMS CORPORATION (Japan)
      7. Cardinal Health (U.S)
      8. F. Hoffmann-La Roche Ltd (Siwtzerland)
      9. GENERAL ELECTRIC (U.S.)
      10. Genentech, Inc. (U.S.)
      11. Hitachi Medical Systems (Japan)
      12. Johnson & Johnson Services, Inc. (U.S.)
      13. Koninklijke Philips N.V. (Netherlands)
      14. Medtronic (Ireland)
      15. Merck & Co., Inc. (U.S.)
      16. Neusoft Corporation (China)
      17. Siemens Healthcare Private Limited (Germany)
      18. Stryker (U.S.)
      19. Sanofi (France)
      20. Teleflex Incorporated (U.S.)
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Acute Ischemic Stroke (AIS)market?

The global market of Acute Ischemic Stroke (AIS) is projected to reach USD 2833.46 Mn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Acute Ischemic Stroke (AIS)market?

The global Acute Ischemic Stroke (AIS) market has an estimated annual growth rate of 6.7% .

Q.3. What are the recent trends of Acute Ischemic Stroke (AIS)market?

Advancements in thrombectomy devices is one of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Acute Ischemic Stroke (AIS)?

The major companies profiled in this report include Abbott (U.S.), AliveCor, Inc. (U.S.), Bayer AG (Germany), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), CANON MEDICAL SYSTEMS CORPORATION (Japan), Cardinal Health (U.S), F. Hoffmann-La Roche Ltd (Switzerland), GENERAL ELECTRIC (U.S.), Genentech, Inc. (U.S.), Hitachi Medical Systems (Japan), Johnson & Johnson Services, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), Merck & Co., Inc. (U.S.), Neusoft Corporation (China), Siemens Healthcare Private Limited (Germany). Stryker (U.S.), Sanofi (France), Teleflex Incorporated (U.S.), among others.

Q.5. Which region is estimated to held highest CAGR inAcute Ischemic Stroke (AIS)market?

North America is estimated to hold biggest share in the market for Acute Ischemic Stroke (AIS).